Natixis
NVCT icon

Natixis’s Nuvectis Pharma NVCT Stock Holding History

Natixis’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$29.9K Buy
+1,414
New +$29.8K ﹤0.01% 1041

Other funds holding NVCT

Iridian Asset Management
Iridian Asset Management Westport, Connecticut $275M AUM 37.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Baldwin Wealth Partners
Baldwin Wealth Partners Marion, Massachusetts $1.52B AUM 21.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
J.M. Forbes & Co
J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Natixis's NVCT Position: Q3 2026 in Review

Natixis opened a new position in Nuvectis Pharma (NVCT) in Q3 2026: 1,414 shares worth $29.9K. The stake represents ﹤0.01% of the portfolio and ranks #1041 among its holdings.

42 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.

  • Natixis held 1,414 shares of Nuvectis Pharma worth $29.9K as of Q3 2026.
  • Nuvectis Pharma was a new Natixis position in Q3 2026.
  • Nuvectis Pharma made up ﹤0.01% of Natixis's portfolio in Q3 2026, its #1041 holding.
  • 42 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.

Based on Natixis's 13F filing for Q3 2026, filed 6 Nov 2026.